Purpose: Pharmacokinetic and safety data related to the use of inhaled insulin for the management of diabetes mellitus are discussed. The various pulmonary insulin delivery systems under ...

MannKind Co. (NASDAQ:MNKD – Get Free Report) has received a consensus rating of “Buy” from the eight brokerages that are ...

Inhaled insulin's pharmacokinetic profile is significantly affected, peaking faster and reaching higher concentrations in smokers compared with nonsmokers, achieving significantly faster onset and ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

One Drop has teamed up with Fitbit to integrate fitness tracker data into its diabetes management platform. The new alliance reflects growing competition in digital health, with many rival digital ...

Another notable innovation in drug delivery in 2015 was MannKind and Sanofi's inhalable insulin Afrezza, launched in February. However the product looks set to be a resounding commercial failure ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

Diabetes is a number of diseases that involve problems with the hormone insulin. There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's ...

After hours: January 31 at 6:49:19 PM EST Loading Chart for MNKD ...

Pre-Market: 8:00:01 a.m. EST ...